[Journal logo]

Volume 65 
Part 6 
Page o1280  
June 2009  

Received 28 April 2009
Accepted 4 May 2009
Online 14 May 2009

Key indicators
Single-crystal X-ray study
T = 173 K
Mean [sigma](C-C) = 0.003 Å
R = 0.044
wR = 0.101
Data-to-parameter ratio = 14.6
Details

(E)-3-[4-(Pentyloxy)phenyl]-1-phenylprop-2-en-1-one

aDepartment of Chemistry, Quaid-i-Azam University Islamabad, 45320-Pakistan, and bInstitut für Anorganische Chemie, J. W. Goethe-Universität Frankfurt, Max-von-Laue-Str. 7, 60438 Frankfurt/Main, Germany
Correspondence e-mail: flavonoids@hotmail.com

The title compound, C20H22O2, crystallizes with two independent molecules in the asymmetric unit. In each molecule, all the non-H atoms lie in a common plane (r.m.s. deviations of 0.098 and 0.079 Å). There is a [pi]-[pi] stacking interaction in the crystal structure. The central aromatic rings of the two molecules, which are stacked head-to-tail one above the other, are separated by centroid-to-centroid distances of 3.872 (13) and 3.999 (10) Å.

Related literature

For background information on chalcones and their properties, see: Achanta et al. (2006[Achanta, G., Modzelewska, A., Feng, L., Khan, S. R. & Huang, P. (2006). Mol. Pharmacol. 70, 426-433.]); Zhang et al. (2009[Zhang, X. D., Hu, X., Hou, A. J. & Wang, H. Y. (2009). Biol. Pharm. Bull. 32, 86-90.]); Tran et al. (2009[Tran, T. D., Park, H., Kim, H. P., Ecker, G. F. & Thai, K. M. (2009). Bioorg. Med. Chem. Lett. 19, 1650-1653.]); Yagura et al. (2008[Yagura, T., Motomiya, T., Ito, M., Honda, G., Iida, A., Kiuchi, F., Tokuda, H. & Nishino, H. (2008). J. Nat. Med. 62, 174-178.]); Sarissky et al. (2008[Sarissky, M., Pilatova, M., Perjesi, P., Mojzis, J. & Sulla, I. (2008). Neuro Oncology. 10, 1112-1112.]); Tang et al. (2008[Tang, Y. X., Simoneau, A. R., Xie, J., Shahandeh, B. & Zi, X. L. (2008). Cancer Prevent. Res. 1, 439-451.]); Srivastava et al. (2008[Srivastava, S. S., Joshi, S., Singh, A. R., Yadav, S., Saxena, A. S., Ram, V. J., Chandra, S. & Saxena, J. K. (2008). Med. Chem. Res. 17, 234-244.]); For bond-length data, see: Allen et al. (1987[Allen, F. H., Kennard, O., Watson, D. G., Brammer, L., Orpen, A. G. & Taylor, R. (1987). J. Chem. Soc. Perkin Trans. 2. pp. S1-19.]). For related structures, see: Rosli et al. (2006[Rosli, M. M., Patil, P. S., Fun, H.-K., Razak, I. A. & Dharmaprakash, S. M. (2006). Acta Cryst. E62, o1466-o1468.]); Harrison et al. (2006[Harrison, W. T. A., Yathirajan, H. S., Sarojini, B. K., Narayana, B. & Vijaya Raj, K. K. (2006). Acta Cryst. E62, o1578-o1579.]). For the synthesis, see: Wattanasin & Murphy (1980[Wattanasin, S. & Murphy, W. S. (1980). Synthesis, 647-650.]).

[Scheme 1]

Experimental

Crystal data
  • C20H22O2

  • Mr = 294.38

  • Monoclinic, P 21 /c

  • a = 7.4881 (4) Å

  • b = 21.3067 (11) Å

  • c = 20.8328 (11) Å

  • [beta] = 93.974 (4)°

  • V = 3315.8 (3) Å3

  • Z = 8

  • Mo K[alpha] radiation

  • [mu] = 0.07 mm-1

  • T = 173 K

  • 0.38 × 0.22 × 0.22 mm

Data collection
  • Stoe IPDS II two-circle-diffractometer

  • Absorption correction: none

  • 25934 measured reflections

  • 5819 independent reflections

  • 3319 reflections with I > 2[sigma](I)

  • Rint = 0.086

Refinement
  • R[F2 > 2[sigma](F2)] = 0.044

  • wR(F2) = 0.101

  • S = 0.82

  • 5819 reflections

  • 398 parameters

  • H-atom parameters constrained

  • [Delta][rho]max = 0.15 e Å-3

  • [Delta][rho]min = -0.19 e Å-3

Table 1
Selected torsion angles (°)

C11-C1-C2-C3 -177.21 (17)
C2-C1-C11-C12 -13.4 (3)
C2-C1-C11-C16 167.85 (17)
C11A-C1A-C2A-C3A -170.05 (18)
C2A-C1A-C11A-C12A -9.5 (3)
C2A-C1A-C11A-C16A 171.52 (17)

Data collection: X-AREA (Stoe & Cie, 2001[Stoe & Cie (2001). X-AREA. Stoe & Cie, Darmstadt, Germany.]); cell refinement: X-AREA; data reduction: X-AREA; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008[Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.]); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008[Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.]); molecular graphics: XP in SHELXTL-Plus (Sheldrick, 2008[Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.]); software used to prepare material for publication: SHELXL97.


Supplementary data and figures for this paper are available from the IUCr electronic archives (Reference: SU2111 ).


Acknowledgements

AA is grateful to the Higher Education Commission of Pakistan for financial support for his PhD program under scholarship No. IIC-0317109.

References

Achanta, G., Modzelewska, A., Feng, L., Khan, S. R. & Huang, P. (2006). Mol. Pharmacol. 70, 426-433.  [PubMed] [ChemPort]
Allen, F. H., Kennard, O., Watson, D. G., Brammer, L., Orpen, A. G. & Taylor, R. (1987). J. Chem. Soc. Perkin Trans. 2. pp. S1-19.
Harrison, W. T. A., Yathirajan, H. S., Sarojini, B. K., Narayana, B. & Vijaya Raj, K. K. (2006). Acta Cryst. E62, o1578-o1579.  [CrossRef] [details]
Rosli, M. M., Patil, P. S., Fun, H.-K., Razak, I. A. & Dharmaprakash, S. M. (2006). Acta Cryst. E62, o1466-o1468.  [CrossRef] [details]
Sarissky, M., Pilatova, M., Perjesi, P., Mojzis, J. & Sulla, I. (2008). Neuro Oncology. 10, 1112-1112.
Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.  [CrossRef] [details]
Srivastava, S. S., Joshi, S., Singh, A. R., Yadav, S., Saxena, A. S., Ram, V. J., Chandra, S. & Saxena, J. K. (2008). Med. Chem. Res. 17, 234-244.  [CrossRef] [ChemPort]
Stoe & Cie (2001). X-AREA. Stoe & Cie, Darmstadt, Germany.
Tang, Y. X., Simoneau, A. R., Xie, J., Shahandeh, B. & Zi, X. L. (2008). Cancer Prevent. Res. 1, 439-451.  [CrossRef]
Tran, T. D., Park, H., Kim, H. P., Ecker, G. F. & Thai, K. M. (2009). Bioorg. Med. Chem. Lett. 19, 1650-1653.  [CrossRef] [PubMed] [ChemPort]
Wattanasin, S. & Murphy, W. S. (1980). Synthesis, 647-650.  [CrossRef]
Yagura, T., Motomiya, T., Ito, M., Honda, G., Iida, A., Kiuchi, F., Tokuda, H. & Nishino, H. (2008). J. Nat. Med. 62, 174-178.  [CrossRef] [ChemPort]
Zhang, X. D., Hu, X., Hou, A. J. & Wang, H. Y. (2009). Biol. Pharm. Bull. 32, 86-90.  [CrossRef] [PubMed]


Acta Cryst (2009). E65, o1280  [ doi:10.1107/S1600536809016754 ]

This is an open-access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are cited.